全文获取类型
收费全文 | 62128篇 |
免费 | 10361篇 |
国内免费 | 772篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 770篇 |
妇产科学 | 534篇 |
基础医学 | 4173篇 |
口腔科学 | 186篇 |
临床医学 | 5398篇 |
内科学 | 9489篇 |
皮肤病学 | 358篇 |
神经病学 | 751篇 |
特种医学 | 694篇 |
外国民族医学 | 2篇 |
外科学 | 717篇 |
综合类 | 7721篇 |
现状与发展 | 11篇 |
预防医学 | 38721篇 |
眼科学 | 120篇 |
药学 | 1996篇 |
11篇 | |
中国医学 | 253篇 |
肿瘤学 | 1332篇 |
出版年
2024年 | 111篇 |
2023年 | 1321篇 |
2022年 | 2380篇 |
2021年 | 2789篇 |
2020年 | 3546篇 |
2019年 | 2346篇 |
2018年 | 2297篇 |
2017年 | 1555篇 |
2016年 | 2651篇 |
2015年 | 3414篇 |
2014年 | 5374篇 |
2013年 | 4978篇 |
2012年 | 7049篇 |
2011年 | 6848篇 |
2010年 | 5668篇 |
2009年 | 4278篇 |
2008年 | 2948篇 |
2007年 | 3600篇 |
2006年 | 2650篇 |
2005年 | 1588篇 |
2004年 | 1178篇 |
2003年 | 996篇 |
2002年 | 672篇 |
2001年 | 535篇 |
2000年 | 454篇 |
1999年 | 443篇 |
1998年 | 195篇 |
1997年 | 132篇 |
1996年 | 154篇 |
1995年 | 111篇 |
1994年 | 81篇 |
1993年 | 73篇 |
1992年 | 128篇 |
1991年 | 76篇 |
1990年 | 83篇 |
1989年 | 67篇 |
1988年 | 39篇 |
1987年 | 23篇 |
1985年 | 51篇 |
1984年 | 31篇 |
1982年 | 23篇 |
1981年 | 24篇 |
1980年 | 42篇 |
1979年 | 42篇 |
1978年 | 26篇 |
1977年 | 30篇 |
1976年 | 27篇 |
1974年 | 25篇 |
1973年 | 22篇 |
1972年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
83.
BackgroundThe Affordable Care Act (ACA) Medicaid expansion varies in availability across states.PurposeWe compared characteristics of low-income uninsured residents in both Medicaid nonexpanding and expanding states with respect to their dietary quality, health risk factors, and access to care.MethodsData from the 2007–2012 National Health and Nutrition Examination Survey was matched with the Kaiser Family Foundation Medicaid expansion data. Bivariate and multivariate regressions were estimated to assess differences across expanding and non-expanding states.ResultThe non-expansion group had a lower Healthy Eating Index score (41.8 vs. 44.1, p-value = 0.006), a higher Body Mass Index (29.9 vs. 28.9, p-value = 0.032), higher obesity prevalence (41% vs. 33%, p-value = 0.007), and lower asthma prevalence (14.8% vs. 19.7%, p-value = 0.037) compared with the expansion group.ConclusionsDifferences across states in Medicaid coverage under the ACA may lead to widening disparities in health outcomes between expanding and non-expanding states. 相似文献
84.
背景与目的:结直肠癌(colorectal cancer,CRC)为世界第三常见恶性肿瘤,近年来研究者认为白细胞介素(interleukin,IL)-35和(或)IL-37与CRC的发展有关,但其作用机制尚未阐明。探究IL-35和IL-37在CRC发展中的作用及其可能的机制,分析IL-35和IL-37与CRC患者预后的相关性。方法:收集2013年—2017年在上海交通大学医学院附属同仁医院接受治疗的191例CRC患者手术病理蜡块的肿瘤组织,与其匹配的非癌组织是来源于同一患者的肠癌手术切缘蜡块组织。应用免疫组织化学(immunohistochemistry,IHC)染色法将CRC患者的癌组织与非癌组织染色,并运用Image-Pro Plus将IHC染色阳性部分定量分析,结合随访结果,探讨癌组织与非癌组织中IL-35和IL-37的表达水平与CRC临床病理学特征及预后的相关性。结果:与非癌组织相比,CRC组织中IL-35的表达量减少了50%(P<0.000 1)。CRC组织中IL-37的表达量与非癌组织相比增加了40%(P=0.012)。多因素生存分析显示,癌组织中IL-35(HR=0.39;95% CI:0.16~0.97;P=0.04)的表达水平是CRC患者术后生存的独立预测指标。结论:IL-35和IL-37蛋白的表达水平可能与CRC的发展有关,IL-35的表达水平可能是CRC患者术后生存的独立预测指标。 相似文献
85.
86.
Henningfield brilliantly dissected the deadly comprehensive tactics of the tobacco industry but Food and Drug Administration and WHO strategies against the tobacco epidemic must be questioned. The Food and Drug Administration has the authority to regulate tobacco production (2009 Tobacco Control Act) but fails to ban menthol and reduce cigarettes nicotine content. As little has changed, the Healthy People 2010 objective of reducing the prevalence of cigarette smoking among adults to 12% by 2010 in the US will be attained by 2030. The monitoring of the WHO Framework Convention on Tobacco Control (WHO FCTC) is passive, even when governments repeatedly violate the Article 5.3 of the Convention, which specifically requires protecting public policy from tobacco industry interference. Since 2004, the year after the adoption of the Convention, the prevalence of daily smoking has leveled off and the 2012 annualized rate of change in prevalence of daily smoking was almost null. This contrasts with a 2% annual decrease in the prevalence of daily smoking from 1980 to 2004. The tobacco endgame needs acts, not bureaucracies. Two counties have been moving forward, Brazil has banned menthol and Australia has implemented plain packaging. 相似文献
87.
According to conservative estimates, >230 million people are infected with schistosomiasis,which becomes one of the most common parasitic diseases. This study focuses on investigating in vivo and in vitro effects of mmu-miR-92a-2-5p in Schistosoma japonicum-induced liver fibrosis by targeting TLR2. Through bioinformatic analysis, the overexpression of TLR2 and the down-regulation of mmu-miR-92a-2-5p were revealed in the progression of S. japonicum-induced liver fibrosis. BALB/C mice were taken advantage to construct normal control and schistosomiasis liver fibrosis (SLF) model. The mice in model groups were transfected recombinant lentivirus (Lenti-mmu-miR-92a-2-5p or Lenti-NC) to alter the expression of mmu-miR-92a-2-5p in vivo. HE and Masson staining were employed to observe the pathological changes and collagenous fibrosis. QRT-PCR showed that mmu-miR-92a-2-5p was decreased while TLR2 was elevated in the infected groups. However, lenti-mmu-miR-92a-2-5p group could inhibit liver fibrosis. Then the effect of mmu-miR-92a-2-5p on S. japonicum-induced liver fibrosis including cell apoptosis rates, proliferation and proteins related to liver fibrosis was examined in NIH-3T3 mouse embryonic fibroblasts. Moreover, the association between mmu-miR-92a-2-5p and TLR2 was detected by dual-luciferase reporter gene assay and the expression of cytokines IL-4, IFN-γ and TNF-α in SLF model was detected by ELISA. Further, the knockout of TLR2 in C57BL/6J mice was used to confirm the association between mmu-miR-92a-2-5p and TLR2. Thus, these findings demonstrated that mmu-miR-92a-2-5p inhibited S. japonicum-induced liver fibrosis by targeting TLR2 in vitro and in vivo. 相似文献
88.
BackgroundTo investigate boosting effects on treatment stabilization in the mandatory treatment modality for patients of amphetamine-type stimulant use disorder.MethodsThis is a retrospective follow-up study over a period from January 2013 to December 2018. We analyzed 425 patients of amphetamine-type stimulant use disorder under mandating treatments. Treatment stabilization for a given patient was defined once 4 negative urinalysis had been observed. We developed a dynamic monitoring model of boosting effects informed by the available data, specifically the number of negative urine samples required to reach stabilization, the sum of urinalyses done at the time when the given number of negative urine samples had been observed and who the patient was. To represent the simulated population, a Monte Carlo method was used to generate p-values from 1000 experiments conducted on a computer.ResultsIn the observed samples, the probability of 4 negative results in urinalysis from 4 outpatient visits was 75.5%. In comparison, the probability for achieving 4th negative results in urinalysis over 4 visits from negative binominal distribution was 57.3%, and from the computer simulation, 49.8%. The observed samples had significantly higher probability of achieving 4 negative results in urinalysis over 4 outpatient visits (p < 0.001).ConclusionsThe mandatory treatment modality boosted treatment stabilization for patients of amphetamine-type stimulant use disorder. The major benefit of using the monitoring model is the ability to monitor boosting effects of stabilization. Results supported the effectiveness of this mandatory treatment modality and can be implemented in deferred-prosecution based treatment modality. 相似文献
89.
90.
《Vaccine》2020,38(51):8185-8193
BackgroundWhile administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral immunity to the rubella component of MMR vaccine has not been widely studied among older adolescents and adults.MethodsIn this longitudinal study, we sought to assess the durability of rubella virus (RV)-specific humoral immunity in a healthy population (n = 98) of adolescents and young adults at two timepoints: ~7 and ~17 years after two doses of MMR-II® vaccination. Levels of circulating antibodies specific to RV were measured by ELISA and an immune-colorimetric neutralization assay. RV-specific memory B cell responses were also measured by ELISpot.ResultsRubella-specific IgG antibody titers, neutralizing antibody titers, and memory B cell responses declined with increasing time since vaccination; however, these decreases were relatively moderate. Memory B cell responses exhibited a greater decline in men compared to women.ConclusionsCollectively, rubella-specific humoral immunity declines following vaccination, although subjects’ antibody titers remain well above the currently recognized threshold for protective immunity. Clinical correlates of protection based on neutralizing antibody titer and memory B cell ELISpot response should be defined. 相似文献